Wednesday, December 23, 2015 10:33:14 AM
THE COMPANY ISSUED 77 MILLION SHARES AND RECEIVED NO CASH OR ASSETS IN EXCHANGE.
MILLIONS OF SHARED ISSUED FOR TOXIC CONVERTIBLE DEBT EXCHANGE.
MILLIONS OF SHARES BEING PRINTED, TOXIC Convertible Notes Payable being converted at .0025.
Since the beginning of the year 24,000,000 shares converted at .0025
Note holders converted $50,000-60,000 of debt into shares valued over $10,000,000
Shareholders being fleeced!
Buyer beware!
$292,000 of CONVERTABLE debt will add another 140,000,000 shares.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM